PSMB9 and cardiac hypertrophy: In the current study, we provide first evidence that the inducible subunit Lmp2 is required to prevent an aggravated manifestation of concentric cardiac hypertrophy with reduced cardiac function and increased matrix development in a noninflammatory model.